Dr. Chelain R. Goodman is an Assistant Professor in the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. Her clinical expertise is in the treatment of early-stage and locally advanced breast cancer using radiotherapy. D r. Goodman’s research interests focus on the identification and validation of novel tumor- and patient-derived biomarkers to tailor radiotherapy treatment decisions and techniques. She is a Breast Cancer Research Foundation (BCRF) Investigator and is the current awardee of the American Society for Radiation Oncology (ASTRO)-BCRF Career Development Award to End Breast Cancer. The ultimate goal of Dr. Goodman’s research program is to improve the quality of care by moving towards more personalized “precision” radiotherapy for the treatment of breast cancer.